175 related articles for article (PubMed ID: 30984349)
1. Albumin-to-alkaline phosphatase ratio: A novel prognostic index of overall survival in cholangiocarcinoma patients after surgery.
Xiong JP; Long JY; Xu WY; Bian J; Huang HC; Bai Y; Xu YY; Zhao HT; Lu X
World J Gastrointest Oncol; 2019 Jan; 11(1):39-47. PubMed ID: 30984349
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of the preoperative albumin to alkaline phosphatase ratio in patients with non-small cell lung cancer after surgery.
Zhang L; Zhang H; Yue D; Wei W; Chen Y; Zhao X; Zhu J; Zhang B; Zhang Z; Wang C
Thorac Cancer; 2019 Jul; 10(7):1581-1589. PubMed ID: 31161711
[TBL] [Abstract][Full Text] [Related]
3. Albumin-to-Alkaline Phosphatase Ratio is an Independent Prognostic Indicator in Combined Hepatocellular and Cholangiocarcinoma.
Zhang F; Lu S; Tian M; Hu K; Chen R; Zhang B; Ren Z; Shi Y; Yin X
J Cancer; 2020; 11(17):5177-5186. PubMed ID: 32742464
[No Abstract] [Full Text] [Related]
4. The prognostic significance of Albumin-to-Alkaline Phosphatase Ratio in upper tract urothelial carcinoma.
Tan P; Xie N; Ai J; Xu H; Xu H; Liu L; Yang L; Wei Q
Sci Rep; 2018 Aug; 8(1):12311. PubMed ID: 30120312
[TBL] [Abstract][Full Text] [Related]
5. Albumin-to-alkaline phosphatase ratio as a novel prognostic indicator for patients undergoing minimally invasive lung cancer surgery: Propensity score matching analysis using a prospective database.
Li SJ; Lv WY; Du H; Li YJ; Zhang WB; Che GW; Liu LX
Int J Surg; 2019 Sep; 69():32-42. PubMed ID: 31319230
[TBL] [Abstract][Full Text] [Related]
6. The Predictive Value of Albumin-to-Alkaline Phosphatase Ratio for Overall Survival of Hepatocellular Carcinoma Patients Treated with Trans-Catheter Arterial Chemoembolization Therapy.
Chen ZH; Zhang XP; Cai XR; Xie SD; Liu MM; Lin JX; Ma XK; Chen J; Lin Q; Dong M; Wu XY; Wen JY; Xu RH
J Cancer; 2018; 9(19):3467-3478. PubMed ID: 30310503
[No Abstract] [Full Text] [Related]
7. The Prognostic Value of Preoperative Albumin-to-Alkaline Phosphatase Ratio on Survival Outcome for Patients With Locally Advanced Oral Squamous Cell Carcinoma.
Tsai MH; Chuang HC; Lin YT; Yang KL; Lu H; Huang TL; Tsai WL; Su YY; Fang FM
Technol Cancer Res Treat; 2022; 21():15330338221141254. PubMed ID: 36426570
[No Abstract] [Full Text] [Related]
8. The Prognostic Significance Of Pretreatment Albumin/alkaline Phosphatase Ratio In Patients With Stage IB-IIA Cervical Cancer.
Zhang C; Li Y; Ji R; Zhang W; Zhang C; Dan Y; Qian H; He A
Onco Targets Ther; 2019; 12():9559-9568. PubMed ID: 32009792
[TBL] [Abstract][Full Text] [Related]
9. Albumin-to-Alkaline Phosphatase Ratio as an Independent Prognostic Factor for Overall Survival of Advanced Hepatocellular Carcinoma Patients without Receiving Standard Anti-Cancer Therapies.
Cai X; Chen Z; Chen J; Ma X; Bai M; Wang T; Chen X; Wu D; Wei L; Li X; Lin Q; Wen J; Ruan D; Lin Z; Dong M; Wu X
J Cancer; 2018; 9(1):189-197. PubMed ID: 29290785
[No Abstract] [Full Text] [Related]
10. Prognostic Significance of Preoperative Albumin to Alkaline Phosphatase Ratio in Patients with Glioblastoma.
Li J; Zuo M; Zhou X; Xiang Y; Zhang S; Feng W; Liu Y
J Cancer; 2021; 12(19):5950-5959. PubMed ID: 34476009
[No Abstract] [Full Text] [Related]
11. Preoperative albumin-alkaline phosphatase ratio affects the prognosis of patients undergoing hepatocellular carcinoma surgery.
Huang W; Wei S; Dong X; Tang Y; Tang Y; Liu H; Huang J; Yang J
Cancer Biomark; 2024; 39(1):15-26. PubMed ID: 37334579
[TBL] [Abstract][Full Text] [Related]
12. Association Between the Pretreatment Albumin-to-Alkaline Phosphatase Ratio and Clinical Outcomes in Patients With Bladder Cancer Treated With Radical Cystectomy: A Retrospective Cohort Study.
Li S; Lu S; Liu X; Chen X
Front Oncol; 2021; 11():664392. PubMed ID: 33959511
[TBL] [Abstract][Full Text] [Related]
13. Albumin-to-Alkaline Phosphatase Ratio as a Novel Prognostic Factor in Patients Undergoing Nephrectomy for Non-Metastatic Renal Cell Carcinoma: Propensity Score Matching Analysis.
Won I; Shim SR; Kim SI; Kim SJ; Cho DS
Clin Genitourin Cancer; 2022 Jun; 20(3):e253-e262. PubMed ID: 35241381
[TBL] [Abstract][Full Text] [Related]
14. Albumin-to-alkaline phosphatase ratio serves as a prognostic indicator in unresectable pancreatic ductal adenocarcinoma: a propensity score matching analysis.
Zhang K; Dong S; Jing YH; Gao HF; Chen LY; Hua YQ; Chen H; Chen Z
BMC Cancer; 2020 Jun; 20(1):541. PubMed ID: 32517802
[TBL] [Abstract][Full Text] [Related]
15. The impact of serum albumin-to-alkaline phosphatase ratio in cervical cancer patients treated with definitive chemoradiotherapy.
Onal C; Gultekin M; Yavas G; Oymak E; Yuce Sari S; Guler OC; Yigit E; Yildiz F
J Obstet Gynaecol; 2022 Aug; 42(6):2426-2432. PubMed ID: 35653776
[TBL] [Abstract][Full Text] [Related]
16. Albumin-to-alkaline phosphatase ratio as a promising indicator of prognosis in human cancers: is it possible?
An L; Yin WT; Sun DW
BMC Cancer; 2021 Mar; 21(1):247. PubMed ID: 33685425
[TBL] [Abstract][Full Text] [Related]
17. Albumin-to-alkaline phosphatase ratio as a predictor of tumor recurrence and prognosis in patients with early-stage hepatocellular carcinoma undergoing radiofrequency ablation as initial therapy.
Zhang F; Lu SX; Hu KS; Gan YH; Chen Y; Ge NL; Yang BW; Zhang L; Chen RX; Ren ZG; Yin X
Int J Hyperthermia; 2021; 38(1):1-10. PubMed ID: 33400889
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of Albumin-to-Alkaline Phosphatase Ratio for
Gan Y; Ren J; Xian J; Yu H; Jin J; Li D; Li W
Int J Gen Med; 2022; 15():3405-3416. PubMed ID: 35378914
[TBL] [Abstract][Full Text] [Related]
19. Validation of the Prognostic Value of Preoperative Albumin-to-Alkaline Phosphatase Ratio in Patients with Surgically Treated Non-Metastatic Renal Cell Carcinoma.
Hu X; Yang ZQ; Dou WC; Shao YX; Wang YH; Lia T; Li X
Onco Targets Ther; 2020; 13():8287-8297. PubMed ID: 32903862
[TBL] [Abstract][Full Text] [Related]
20. Prognostic role of pretreatment albumin-to-alkaline phosphatase ratio in locally advanced laryngeal and hypopharyngeal cancer: Retrospective cohort study.
Wu J; You K; Jiang Y; Shen T; Song J; Chen C; Liu Y
J Cancer; 2021; 12(20):6182-6188. PubMed ID: 34539891
[No Abstract] [Full Text] [Related]
[Next] [New Search]
